Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Up 2.6% – What’s Next?

Bayer Aktiengesellschaft (ETR:BAYN)’s stock price was up 2.6% during mid-day trading on Thursday . The stock traded as high as €40.37 and last traded at €39.59. 3,571,930 shares changed hands during mid-day trading, The stock had previously closed at €38.60.

Bayer Aktiengesellschaft Trading Up 2.6%

The business’s 50 day moving average is €37.78 and its two-hundred day moving average is €39.42. The company has a quick ratio of 0.72, a current ratio of 1.06 and a debt-to-equity ratio of 134.81. The firm has a market capitalization of $39.97 billion, a P/E ratio of -45.42, a PEG ratio of 36.39 and a beta of 0.84.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.